Navigation path

Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information

Complement factor H

EU orphan designation number: EU/3/06/425
Active ingredient: Complement factor H
Indication: Treatment of atypical Haemolytic Uraemic Syndrome (aHUS) associated with an inherited abnormality of the complement system
Sponsor: Laboratoire français du Fractionnement et des Biotechnologies (LFB) S.A.
3 avenue des Tropiques, BP 80097, 91943 Courtaboeuf CEDEX, France

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/01/2007 Orphan designation EMEA/OD/080/06 (2007)317 of 26/01/2007
13/06/2012 Removal of orphan designation from Community Register